| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
11 companies
Gordon Carl L is a Director, 10% Owner at Alector, Inc. with holdings across 11 companies. Recent SEC Form 4 filings include 11 buys and 0 sells.
Estimated insider holdings value: $415.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 19, 2020 | CMPX Compass Therapeutics, Inc. | Director, 10% Owner | Buy | 1,455,132 | $5.00 | $7,275,660.00 | +12.9% | |
| Apr 24, 2020 | ORIC Oric Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 281,250 | $16.00 | $4,500,000.00 | New | |
| Apr 13, 2020 | KROS Keros Therapeutics, Inc. | Director | Buy | 375,200 | $16.00 | $6,003,200.00 | +50.4% | |
| Feb 11, 2019 | ALEC Alector, Inc. | Director, 10% Owner | Buy | 411,700 | $19.00 | $7,822,300.00 | +3.2% | |
| Nov 20, 2017 | XFOR X4 Pharmaceuticals, Inc | Director, 10% Owner | Buy | 500,000 | $10.00 | $5,000,000.00 | +36.5% | |
| Jun 27, 2016 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 550,000 | $14.00 | $7,700,000.00 | +42.5% | |
| May 11, 2016 | NTLA Intellia Therapeutics, Inc. | Director | Buy | 250,000 | $18.00 | $4,500,000.00 | +5.0% |